Next Article in Journal
Diverse Roads Taken by 13C-Glucose-Derived Metabolites in Breast Cancer Cells Exposed to Limiting Glucose and Glutamine Conditions
Previous Article in Journal
Proteomic Analysis of miR-195 and miR-497 Replacement Reveals Potential Candidates that Increase Sensitivity to Oxaliplatin in MSI/P53wt Colorectal Cancer Cells

HtrA4 Protease Promotes Chemotherapeutic-Dependent Cancer Cell Death

Department of General and Medical Biochemistry, Faculty of Biology, University of Gdansk, Wita Stwosza 59, 80-308 Gdansk, Poland
Laboratory of Virus Molecular Biology, Intercollegiate Faculty of Biotechnology, University of Gdansk and Medical University of Gdansk, Abrahama 58, 80-307 Gdansk, Poland
Author to whom correspondence should be addressed.
Cells 2019, 8(10), 1112;
Received: 14 August 2019 / Revised: 12 September 2019 / Accepted: 18 September 2019 / Published: 20 September 2019
(This article belongs to the Section Cell Signaling)
The HtrA4 human protease is crucial in placentation and embryo implantation, and its altered level is connected with pre-eclampsia. The meta-analyses of microarray assays revealed that the HtrA4 level is changed in brain tumors and breast and prostate cancers, which suggests its involvement in oncogenesis. In spite of the HtrA4 involvement in important physiological and pathological processes, its function in the cell is poorly understood. In this work, using lung and breast cancer cell lines, we showed for the first time that the full-length HtrA4 and its N-terminally deleted variant promote cancer cell death induced by chemotherapeutic drugs by enhancing apoptosis. The effect is dependent on the HtrA4 proteolytic activity, and the N-terminally deleted HtrA4 is more efficient in the cell death stimulation. Furthermore, HtrA4 increases the effect of chemotherapeutics on the clonogenic potential and motility of cancer cells, and it increases cell cycle arrest at the G2/M phase. HtrA4 may modulate cell death by degrading the anti-apoptotic XIAP protein and also by proteolysis of the executioner pro-caspase 7 and cytoskeletal proteins, actin and β-tubulin. These findings provide new insight into the mechanism of the HtrA4 protease function in cell death and oncogenesis, and they may help to develop new anti-cancer therapeutic strategies. View Full-Text
Keywords: HtrA proteins; HtrA4 protease; apoptosis; oncogenesis; cancer HtrA proteins; HtrA4 protease; apoptosis; oncogenesis; cancer
Show Figures

Graphical abstract

MDPI and ACS Style

Wenta, T.; Rychlowski, M.; Jarzab, M.; Lipinska, B. HtrA4 Protease Promotes Chemotherapeutic-Dependent Cancer Cell Death. Cells 2019, 8, 1112.

AMA Style

Wenta T, Rychlowski M, Jarzab M, Lipinska B. HtrA4 Protease Promotes Chemotherapeutic-Dependent Cancer Cell Death. Cells. 2019; 8(10):1112.

Chicago/Turabian Style

Wenta, Tomasz, Michal Rychlowski, Miroslaw Jarzab, and Barbara Lipinska. 2019. "HtrA4 Protease Promotes Chemotherapeutic-Dependent Cancer Cell Death" Cells 8, no. 10: 1112.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop